BRCA Mutations Treatment Market Trends

Growth Drivers

• Rising prevalence of chronic diseases - There has been an increasing number of people dealing with chronic diseases. The rising need for chronic disease management will help the BRCA mutations treatment market to rise.
  
  According to the National Library of Medicine, the number of people 50 years of age and older who have at least one chronic condition is predicted to rise from 71.52o million (69.065–73.781) in 2020 to 142.66 million (134.74–153.39) in 2050, a 99.5% (95.1%−107.9%) increase. The next sections of this paper thoroughly evaluate and debate the most recent scientific information about the type and strength of the relationships between nutrition and chronic diseases.
   
• The increasing patent pool suffering from cancer - Patent pools, which enable third parties to purchase non-exclusive licenses for the intellectual property required to manufacture products, are one way to improve access to innovative medications.
  
  Research stated that making use of the EPO's carefully selected patent data demonstrates a notable increase in innovation targeted at the fight against cancer in the last few years. The patenting increased by over 70%, or almost 10%, yearly between 2015 and 2021.
   
• Rising investment in healthcare infrastructure globally - The continuous epidemic still requires healthcare systems' attention and resources, but the global healthcare industry is rising to the challenge.
  
  By altering the kind, extent, and location of work, rapidly increasing patient access to virtual health services, and forming partnerships to produce and get the required drugs, treatments, and supplies, they continuously improve the quality of life for their staff members.
  
  Additionally, in line with the World Health Organization, it has been projected that a significant amount of money roughly USD 31.1 billion annually will be needed to prepare for future pandemics, with around a third coming from foreign funding.

Challenges

• High cost of cancer treatment - The cost of life-saving therapies increases in tandem with the rise in cancer survival rates. The monthly cost of medications can approach USD 100,000, leaving many Americans grappling with the psychological and physical consequences of significant out-of-pocket medical expenses.
  
  Worse still, some people are priced out of any chance of a recovery. Cancer treatment expenses are influenced by several factors. Of polled cancer patients, nearly half responded that their financial status was negatively impacted by treatment-related travel expenses.
   
• Lack of knowledge in people globally - Breast, ovarian, fallopian tube, primary peritoneal, and prostate cancers are among the malignancies that are associated with mutations in the BRCA1 and BRCA2 genes. If a person has inherited a deleterious BRCA1 or BRCA2 variation, genetic testing can detect this, albeit it is not currently advised for the general population, but people are not that aware of it.